Details for 2015703321
Up to date per 08.05.2026
Actions
Details for 2015703321
Granted/Registered
European Patent
23.11.2016 A
08.08.2018 B1
17.01.2014
US
201461928754 P
09.05.2014
US
201461991129 P
C07D 241/18 20060101AFI20150729BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
CHEN, Christine Hiu-tungNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
CHEN, ZhuoliangNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
DORE, MichaelNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
FORTANET, Jorge GarciaNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
KARKI, RajeshNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
KATO, MitsunoriNovartis Institutes for BioMedical Research, Inc. 100 Technology Square Cambridge, MA 02139US
LAMARCHE, Matthew J.Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
PEREZ, Lawrence BlasNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
SMITH, Troy DouglasNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
WILLIAMS, SarahNovartis Institutes for BioMedical Research, Inc. 100 Technology Square Cambridge, MA 02139US
GIRALDES, John WilliamNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
TOURE, Bakary-barryNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
SENDZIK, MartinNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US
Information about Fees